Christina D. Smolke is Professor in the Department of Bioengineering and, by courtesy, Chemical Engineering at Stanford University. Christina’s academic research program develops foundational tools that drive transformative advances in our ability to engineering biology. Her group pioneered the development of yeast biosynthesis platforms for complex plant-based alkaloids, including the opioids and noscapinoids. Christina is also Co-Founder and CEO of Antheia, which leverages advances in synthetic biology, genomics, informatics, and fermentation to transform how we make and discover important medicines. Her impact in advancing the frontiers of biotechnology has been recognized with numerous awards, including Chan Zuckerberg Biohub Investigator, Nature’s 10, AIMBE College of Fellows, NIH Director’s Pioneer Award, WTN Award in Biotechnology, and TR35 Award.